Consumption and tax gains attributable to Covid-19 vaccinations in 12 EU countries with low vaccination rates
European Journal of Public Health · 01.04.2023 · 33 (2) · 228-234
DOI: 10.1093/eurpub/ckad023 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Public Health, online erschienen am 13.02.2023. Verfasst von Jonathan Cylus und 3 weiteren Autor:innen. Beteiligte Einrichtung: European Observatory on Health Systems and Policies, London, UK. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization, Development of the Covid-19 Taxination Simulator, ACT Accelerator.
Abstract (Originalsprache)
Background
The Covid-19 pandemic is an economic and a health crisis. Households reduced consumption expenditures as large-scale physical distancing measures, lower disposable incomes and fear of infection when engaging in many types of economic activity took hold. This, in turn, reduced domestic tax revenues at a time when governments were facing increased financial pressures to strengthen and sustain welfare states.
Methods
We developed a simulation model, the Covid-19 Taxination Simulator, to estimate potential economic gains and tax revenues attributable to vaccine rollouts. We apply the model to 12 European Union countries which had low vaccination rates at the beginning of 2022.
Results
The highest growth in aggregate personal consumption expenditure attributable to Covid-19 vaccines administered as of January 2022 is in Greece (10.8%), Slovenia (8.6%) and Czechia (8.6%), while the lowest is in Bulgaria (2.2%) and Slovakia (2.1%). If countries had vaccinated 85% of their adult population, the largest gains in consumption tax revenues would be expected in Romania (830 million Euros) and Poland (738 million Euros). Consumption tax revenues generated by meeting the 85% of the adult population target would, on their own, be large enough to fully cover the costs of expanding the vaccine rollout itself in Estonia, Latvia, Slovenia, Croatia, Czechia, Hungary and Greece.
Conclusion
Covid-19 vaccination rollouts not only save lives and relieve pressures on health systems, they also support economic growth and generate additional tax revenues. These revenues can partially offset the costs of vaccines programmes themselves.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- European Observatory on Health Systems and Policies, London, UK.
- LSE Health, Department of Health Policy, London School of Economics and Political Science, London, UK.
- Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.
- WHO Barcelona Office for Health Systems Financing, World Health Organization Regional Office for Europe, Barcelona, Spain.
- Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain.
- Brown University School of Public Health, Providence, USA.
ORCID-Profile: Martin McKee
Förderung
- World Health Organization
- Development of the Covid-19 Taxination Simulator
- ACT Accelerator
Zitieren
APA
Cylus, J., Walters, J., McKee, M., & Cowley, P. (2023). Consumption and tax gains attributable to Covid-19 vaccinations in 12 EU countries with low vaccination rates. European Journal of Public Health, 33(2), 228-234. https://doi.org/10.1093/eurpub/ckad023
Vancouver
Cylus J, Walters J, McKee M, Cowley P. Consumption and tax gains attributable to Covid-19 vaccinations in 12 EU countries with low vaccination rates. European Journal of Public Health. 2023;33(2):228-234. doi:10.1093/eurpub/ckad023
BibTeX
@article{Cylus2023,
author = {Cylus, Jonathan and Walters, Jessica and McKee, Martin and Cowley, Peter},
title = {Consumption and tax gains attributable to Covid-19 vaccinations in 12 EU countries with low vaccination rates},
journal = {European Journal of Public Health},
year = {2023},
volume = {33},
number = {2},
pages = {228--234},
doi = {10.1093/eurpub/ckad023}
}
EUVIMED